Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 16Carcinoma, Non-Small-Cell Lung 7Ovarian Neoplasms 5Uterine Cervical Neoplasms 4Stomach Neoplasms 3Neoplasms 3Lung Neoplasms 3Endometrial Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Intraductal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Thrombosis 1Stage IA Uterine Sarcoma 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Solid Tumor Cancer 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Peripheral Nervous System Diseases 1Pancreatic Cyst 1Pain 1Organoid 1Neoplasms, Germ Cell and Embryonal 1NSCLC 1Motor Activity 1Medulloblastoma 1Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer 1

Interventions

Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Organoid × Paclitaxel × Clear all
NCT03544047 2018-12-11

Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model

Peking Union Medical College

Phase NA Unknown
50 enrolled

Organoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡